Merger Builds Japanese Firm For Drug Development Services
This article was originally published in PharmAsia News
Executive Summary
A Japanese merger is expected to lead to an expanded list of services in support of local drug development. An equity stake in Medical Collective Intelligence has brought Itochu into the business of marketing support to drug makers. The merged firm plans to conduct studies pharmaceutical companies have been asking for to determine areas of large need for drug development. The new company also plans to offer a full range of services for the drug industry. (Click here for more - a subscription may be required